mRNA Cancer Vaccine Publications & Research

Peer-reviewed publications on personalised mRNA cancer vaccines, mRNA immunotherapy, and cancer vaccine innovation from the Australian Personalised mRNA Cancer Immunotherapy Hub.

Graphical abstract
mRNArchitect: sequence design of mRNA medicines.
Budzinska MA, Zardbani M, Michelle PS, Waterhouse J, Leonard TE, Ghodasara A, Lakshman Das S, Chang RY, Chaudhary N, Cheetham SW, Mercer TR, Gunter HM.
bioRxiv. 2025 Aug 26. doi: 10.1101/2024.12.03.626696.
Preprint
Graphical abstract
Efficient delivery of mRNA-LNPs in primary and secondary liver cancer.
Leighton LJ, Gee YJ, Madugalle SU, Victorova M, Carrodus NL, Bridle KR, Howell SA, Liang X, Miller GC, McMillan CLD, Wijesundara DK, Muller DA, Crawford DHG, Mercer TR, Cheetham SW.
bioRxiv. 2025 Mar 19. doi: 10.1101/2025.03.18.643845.
Preprint
Graphical abstract
Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers.
Dietmair B, Humphries J, Mercer TR, Thurecht KJ, Howard CB, Cheetham SW.
Mol Ther Nucleic Acids. 2025 Mar 19;36(2):102520.
Free PMC article
Graphical abstract
Mind the cap: Detecting degradation impurities in synthetic mRNAs.
Nielsen D, Victorova M, Mercer TR, Cheetham SW.
Mol Ther Nucleic Acids. 2025 Sep 17;36(4):102701.
Free PMC article
Graphical abstract
The design, manufacture and LNP formulation of mRNA for research use.
Leighton LJ, Chaudhary N, Tompkins HT, Kulkarni A, Carrodus NL, Budzinska MA, Lakshman Das S, Cheetham SW, Mercer TR.
Nat Protoc. 2025 Dec;20(12):3552-3581.
Graphical abstract
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy.
Wong JKM, Lam PY, Coleborn E, Jose J, Alim L, Tu C, Antczak M, Dietmair B, Hagh AG, Noronha L, Cheetham SW, Hooper J, Beavis PA, Merino D, Berthelet J, Aoude LG, McCart-Reed AE, Lakhani S, Simpson PT, Rossi GR, Brooks AJ, Jones ML, Simpson F, Souza-Fonseca-Guimaraes F.
Mol Ther. 2026 Mar 4;34(3):1382-1398.
Graphical abstract
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
Lam PY, Omer N, Wong JKM, Tu C, Alim L, Rossi GR, Victorova M, Tompkins H, Lin CY, Mehdi AM, Choo A, Elliott MR, Coleborn E, Sun J, Mercer T, Vittorio O, Dobson LJ, McLellan AD, Brooks A, Tuong ZK, Cheetham SW, Nicholls W, Souza-Fonseca-Guimaraes F.
Clin Transl Med. 2025 Jan;15(1):e70140.
Free PMC article
Graphical abstract
mRNA vaccine quality analysis using RNA sequencing.
Gunter HM, Idrisoglu S, Singh S, Han DJ, Ariens E, Peters JR, Wong T, Cheetham SW, Xu J, Rai SK, Feldman R, Herbert A, Marcellin E, Tropee R, Munro T, Mercer TR.
Nat Commun. 2023 Sep 21;14(1):5663.
Free PMC article
Graphical abstract
A scalable, spin-free approach to generate enhanced induced pluripotent stem cell-derived natural killer cells for cancer immunotherapy.
Rossi GR, Sun J, Lin CY, Wong JK, Alim L, Lam PY, Khosrotehrani K, Wolvetang E, Cheetham SW, Derrick EB, Amoako A, Lehner C, Brooks AJ, Beavis PA, Souza-Fonseca-Guimaraes F.
Immunol Cell Biol. 2024 Nov;102(10):924-934.
Graphical abstract
Vasculature organotropism in drug delivery.
Amruta A, Iannotta D, Cheetham SW, Lammers T, Wolfram J.
Adv Drug Deliv Rev. 2023 Oct;201:115054.
Free PMC article Review

Collaborate With Us

We provide mRNA cancer vaccine technology, expertise and support for Australian scientists. Get in touch to discuss how we can support your research.

Get in Touch →